Literature DB >> 28482765

Incidental renal tumours on low-dose CT lung cancer screening exams.

Paul F Pinsky1, Barbara Dunn1, David Gierada2, P Hrudaya Nath3, Reginald Munden4, Lincoln Berland3, Barnett S Kramer1.   

Abstract

Introduction Renal cancer incidence has increased markedly in the United States in recent decades, largely due to incidentally detected tumours from computed tomography imaging. Here, we analyze the potential for low-dose computed tomography lung cancer screening to detect renal cancer. Methods The National Lung Screening Trial randomized subjects to three annual screens with either low-dose computed tomography or chest X-ray. Eligibility criteria included 30 + pack-years, current smoking or quit within 15 years, and age 55-74. Subjects were followed for seven years. Low-dose computed tomography screening forms collected information on lung cancer and non-lung cancer abnormalities, including abnormalities below the diaphragm. A reader study was performed on a sample of National Lung Screening Trial low-dose computed tomography images assessing presence of abnormalities below the diaphragms and abnormalities suspicious for renal cancer. Results There were 26,722 and 26,732 subjects enrolled in the low-dose computed tomography and chest X-ray arms, respectively, and there were 104 and 85 renal cancer cases diagnosed, respectively (relative risk = 1.22, 95% CI: 0.9-1.5). From 75,126 low-dose computed tomography screens, there were 46 renal cancer diagnoses within one year. Abnormalities below the diaphragm rates were 39.1% in screens with renal cancer versus 4.1% in screens without (P < 0.001). Cases with abnormalities below the diaphragms had shorter median time to diagnosis than those without (71 vs. 160 days, P = 0.004). In the reader study, 64% of renal cancer cases versus 13% of non-cases had abnormalities below the diaphragms; 55% of cases and 0.8% of non-cases had a finding suspicious for renal cancer (P < 0.001). Conclusion Low-dose computed tomography screens can potentially detect renal cancers. The benefits to harms tradeoff of incidental detection of renal tumours on low-dose computed tomography is unknown.

Entities:  

Keywords:  Lung cancer; incidental findings; low-dose CT; renal cancer; screening

Mesh:

Year:  2016        PMID: 28482765     DOI: 10.1177/0969141316657115

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  3 in total

1.  Lung cancer screening: the path forward.

Authors:  Caroline Chiles; Reginald F Munden
Journal:  Transl Lung Cancer Res       Date:  2018-06

2.  Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening Trial.

Authors:  Holli A Loomans-Kropp; Barbara K Dunn; Barnett S Kramer; Paul Pinsky
Journal:  Am J Epidemiol       Date:  2020-01-31       Impact factor: 4.897

3.  The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.

Authors:  Juliet A Usher-Smith; Angela Godoy; Sarah W Burge; Simon Burbidge; Jon Cartledge; Philip A J Crosbie; Claire Eckert; Fiona Farquhar; David Hammond; Neil Hancock; Gareth R Iball; Michael Kimuli; Golnessa Masson; Richard D Neal; Suzanne Rogerson; Sabrina H Rossi; Evis Sala; Andrew Smith; Stephen J Sharp; Irene Simmonds; Tom Wallace; Matthew Ward; Matthew E J Callister; Grant D Stewart
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.